Newsroom

Articles

Antibiogo is looking for a User Experience Researcher (Freelance)

We are looking for a User Experience Researcher to join Antibiogo team and work on the future development of the application

Read more
Articles

[Freelance] Antibiogo is looking for a Backend Developer (Typescript) and a Computer vision Engineer

We are looking for a Backend Developer (Typescript) and a Computer vision Engineer to join Antibiogo team and work on the development of the application’s new features

Read more
Miniature TIC
Vidéos

[ANTIBIOGO] Antibiogo : A free diagnostic aid application to counter antibiotic resistance.

Articles

“I have huge respect for our teams in the field who face so many difficulties and danger”, says 3D programm physiotherapist Elise Tauveron on her return from Haiti.

In early 2022, the MSF Foundation launched a research study on its 3D compression mask programme for patients with severe burns in Haiti’s capital Port-au-Prince. Elise Tauveron, who has just spent a month with the teams in Haiti, talks about the launch and significance of the study. In early 2022, the MSF Foundation launched a research study on its 3D compression mask programme for patients with severe burns in Haiti’s capital Port-au-Prince. Elise Tauveron, who has just spent a month with the teams in Haiti, talks about the launch and significance of the study.

Read more
Événements

The MSF Foundation will be present at Vivatech from June 15 to 18

The MSF Foundation will be at Viva Technology 2022 - June 15 to 18 in Paris. You will find Antibiogo on the Google.org booth.

Read more
App Antibiogo
Articles

After 5 years of development, Antibiogo becomes the first medical device with CE marking developed by the MSF Foundation!

Read more
Événements

Meet the MSF Foundation at the Nancy burns congress from June 8 to 10

The MSF Foundation will be present at the 41st Congress of the Société Francophone de Brûlologie at the Centre Prouvé in Nancy to talk about the 3D Program.

Read more

Headline

MSF
Articles

Palestine: MSF responds to the Israeli government's smear campaign

For several days, Médecins Sans Frontières and the MSF Foundation have been the target of an online smear campaign.

Keywords associated with our organizations have been misused in several countries to direct internet users to a disinformation website.

In this context, we are sharing MSF’s statement and reaffirming our commitment to continue our humanitarian work with the populations we support.

Read more

MSF Foundation in Video

News

Publications

  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in HIV-infected people in Kenya (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more
  • Publications

    Immunogenicity and safety of fractional doses of 17D-213 yellow fever vaccine in children (YEFE): a randomised, double-blind, non-inferiority substudy of a phase 4 trial

    Read more

Press Review

No news for now.